Pub Date : 2024-09-01Epub Date: 2024-08-31DOI: 10.4103/lungindia.lungindia_399_23
Suikriti Sharma, Deepika Karki, Kanivi Julitta
Background: Inhaled corticosteroids (ICS) are prominent therapies for managing both asthma and chronic obstructive pulmonary disease (COPD). It has been noted that cognitive impairment is usually linked to high levels of corticosteroids in the blood.
Objective: This investigation aims to ascertain how long-term inhaled corticosteroid treatment affects individuals with bronchial asthma and COPD's cognitive performance.
Methodology: A total of 139 inpatients diagnosed with COPD and bronchial asthma were enrolled in the study of which 43 were newly diagnosed (group 1), 34 were taking ICS for 0.5-1 year (group 2) and 62 were on long-term ICS, that is, for >2 years (group 3). Patients with a score of at least 24 were considered to have normal cognitive function as prescribed by the Montreal Cognitive Assessment scale.
Result: It was observed that 56 patients (90.3%) were on long-term ICS treatment, 25 patients (73.5%) were on intermediate therapy and 27 patients (62.7%) who were newly diagnosed had cognitive impairment.
Conclusion: In conclusion, the duration of ICS therapy was significantly associated with a decline in cognitive function.
{"title":"Effect of long-term inhaled corticosteroids therapy on cognitive function in patients with bronchial asthma and chronic obstructive pulmonary disease.","authors":"Suikriti Sharma, Deepika Karki, Kanivi Julitta","doi":"10.4103/lungindia.lungindia_399_23","DOIUrl":"10.4103/lungindia.lungindia_399_23","url":null,"abstract":"<p><strong>Background: </strong>Inhaled corticosteroids (ICS) are prominent therapies for managing both asthma and chronic obstructive pulmonary disease (COPD). It has been noted that cognitive impairment is usually linked to high levels of corticosteroids in the blood.</p><p><strong>Objective: </strong>This investigation aims to ascertain how long-term inhaled corticosteroid treatment affects individuals with bronchial asthma and COPD's cognitive performance.</p><p><strong>Methodology: </strong>A total of 139 inpatients diagnosed with COPD and bronchial asthma were enrolled in the study of which 43 were newly diagnosed (group 1), 34 were taking ICS for 0.5-1 year (group 2) and 62 were on long-term ICS, that is, for >2 years (group 3). Patients with a score of at least 24 were considered to have normal cognitive function as prescribed by the Montreal Cognitive Assessment scale.</p><p><strong>Result: </strong>It was observed that 56 patients (90.3%) were on long-term ICS treatment, 25 patients (73.5%) were on intermediate therapy and 27 patients (62.7%) who were newly diagnosed had cognitive impairment.</p><p><strong>Conclusion: </strong>In conclusion, the duration of ICS therapy was significantly associated with a decline in cognitive function.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"357-361"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472989/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background and objectives: The study aimed to assess the control of asthma and the severity of chronic obstructive pulmonary disease (COPD) and evaluate the adequacy of treatment in patients presenting to the outpatient department (OPD) across India. The secondary aim was to assess the risk factors associated with poorly controlled asthma and severe COPD.
Materials and methods: This is the analysis of Phase IV of the multicenter questionnaire-based point prevalence SWORD survey, conducted in May 2018, and designed to capture details on disease control and treatment as per the global initiative for asthma and the global initiative for chronic obstructive lung disease guidelines.
Results: Of the 5,311 respiratory disease patients presenting to the OPD, there were 1,419 and 412 patients with asthma and COPD, respectively, across 290 sites in India. There were 1,022 (72%) patients having well-controlled asthma, 293 (20.6%) patients with partly controlled asthma, and 104 (7.4%) patients with poorly controlled asthma. Of the 412 patients with COPD, there were 307 (74.5%) in A, 54 (13.1%) in B, and 51 (12.4%) in the E category. In spite of poor control or severe disease, 34.8% of asthmatic and 25.7% of patients in the B and E categories of COPD were not using any medicine. Risk factors for partly and poorly controlled asthma included rain wetting (adjusted odds ratio [AOR]: 1.59, 95% confidence interval [CI]: 1.02-2.47) and gastroesophageal reflux disease (AOR: 1.50, 95%CI: 1.08-2.10).
Conclusion: This study identifies a gap in the treatment of both poorly controlled asthma and severe COPD. A substantial number of patients had poorly controlled asthma and severe COPD, and many were either not taking treatment or taking it inappropriately.
背景和目的:该研究旨在评估哮喘的控制情况和慢性阻塞性肺病(COPD)的严重程度,并评估印度各地门诊部(OPD)就诊患者的治疗是否充分。次要目的是评估与哮喘控制不佳和严重慢性阻塞性肺病相关的风险因素:这是 2018 年 5 月开展的基于多中心问卷的点流行率 SWORD 调查第四阶段的分析,旨在根据全球哮喘倡议和全球慢性阻塞性肺病倡议指南了解疾病控制和治疗的详细情况:在印度 290 个医疗点的 5311 名到门诊部就诊的呼吸系统疾病患者中,分别有 1419 名和 412 名哮喘和慢性阻塞性肺疾病患者。哮喘控制良好的患者有 1022 人(72%),哮喘部分控制的患者有 293 人(20.6%),哮喘控制不佳的患者有 104 人(7.4%)。在 412 名慢性阻塞性肺病患者中,有 307 人(74.5%)属于 A 类,54 人(13.1%)属于 B 类,51 人(12.4%)属于 E 类。尽管病情控制不佳或严重,但 34.8%的哮喘患者和 25.7%的 B 类及 E 类慢性阻塞性肺病患者没有使用任何药物。部分哮喘和哮喘控制不佳的风险因素包括雨天打湿(调整后的几率比[AOR]:1.59,95%置信区间[CI]:1.02-2.47)和胃食管反流病(AOR:1.50,95%置信区间[CI]:1.08-2.10):这项研究发现了在治疗控制不佳的哮喘和严重慢性阻塞性肺疾病方面存在的差距。大量患者的哮喘和严重慢性阻塞性肺疾病控制不佳,其中许多人要么没有接受治疗,要么治疗不当。
{"title":"Assessment of obstructive airway disease in the multicenter SWORD survey India.","authors":"Sheetu Singh, Bharat Bhushan Sharma, Arvind Kumar Sharma, Nishtha Singh, Aradhana Singh, Krishna Kumar Sharma, Tariq Mahmood, Kumar Utsav Samaria, A Sundaramurthy, Surya Kant, Tejraj Singh, Parvaiz A Koul, Virendra Singh","doi":"10.4103/lungindia.lungindia_202_24","DOIUrl":"10.4103/lungindia.lungindia_202_24","url":null,"abstract":"<p><strong>Background and objectives: </strong>The study aimed to assess the control of asthma and the severity of chronic obstructive pulmonary disease (COPD) and evaluate the adequacy of treatment in patients presenting to the outpatient department (OPD) across India. The secondary aim was to assess the risk factors associated with poorly controlled asthma and severe COPD.</p><p><strong>Materials and methods: </strong>This is the analysis of Phase IV of the multicenter questionnaire-based point prevalence SWORD survey, conducted in May 2018, and designed to capture details on disease control and treatment as per the global initiative for asthma and the global initiative for chronic obstructive lung disease guidelines.</p><p><strong>Results: </strong>Of the 5,311 respiratory disease patients presenting to the OPD, there were 1,419 and 412 patients with asthma and COPD, respectively, across 290 sites in India. There were 1,022 (72%) patients having well-controlled asthma, 293 (20.6%) patients with partly controlled asthma, and 104 (7.4%) patients with poorly controlled asthma. Of the 412 patients with COPD, there were 307 (74.5%) in A, 54 (13.1%) in B, and 51 (12.4%) in the E category. In spite of poor control or severe disease, 34.8% of asthmatic and 25.7% of patients in the B and E categories of COPD were not using any medicine. Risk factors for partly and poorly controlled asthma included rain wetting (adjusted odds ratio [AOR]: 1.59, 95% confidence interval [CI]: 1.02-2.47) and gastroesophageal reflux disease (AOR: 1.50, 95%CI: 1.08-2.10).</p><p><strong>Conclusion: </strong>This study identifies a gap in the treatment of both poorly controlled asthma and severe COPD. A substantial number of patients had poorly controlled asthma and severe COPD, and many were either not taking treatment or taking it inappropriately.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"335-344"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11473000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-01Epub Date: 2024-08-31DOI: 10.4103/lungindia.lungindia_234_24
Hineptch Daungsupawong, Viroj Wiwanitkit
{"title":"Managing risk of infectious disease transmission at religious mass gatherings.","authors":"Hineptch Daungsupawong, Viroj Wiwanitkit","doi":"10.4103/lungindia.lungindia_234_24","DOIUrl":"10.4103/lungindia.lungindia_234_24","url":null,"abstract":"","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"400"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-01Epub Date: 2024-08-31DOI: 10.4103/lungindia.lungindia_181_24
Nitin Jain, Manisha Jain, Ashutosh Chaturvedi, Nirmal K Jain
{"title":"Stockout of anti-TB drugs: Are we going to lose the gains achieved in year 2022-2023?","authors":"Nitin Jain, Manisha Jain, Ashutosh Chaturvedi, Nirmal K Jain","doi":"10.4103/lungindia.lungindia_181_24","DOIUrl":"10.4103/lungindia.lungindia_181_24","url":null,"abstract":"","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"333-334"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A case of unusually long apnoea in a young man with obstructive sleep apnoea.","authors":"Kirti Kadian, Alkesh Kumar Khurana, Abhishek Goyal, Prakhar Agarwal","doi":"10.4103/lungindia.lungindia_581_23","DOIUrl":"10.4103/lungindia.lungindia_581_23","url":null,"abstract":"","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"381-382"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472995/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-01Epub Date: 2024-08-31DOI: 10.4103/lungindia.lungindia_154_24
Ganapathy Arumugam C, Kavitha Sekar, R Sridhar, Ajay Narasimhan, R Narasimhan
Abstract: Carinal resection of tumour involving trachea and carina remains as a challenge for thoracic surgeons and anaesthesiologists. Resection is technically demanding and can be associated with significant morbidity and mortality. In this case report, we describe the successful management of carinal tumour with carinal resection in a 45-year-old female. The tumour was involving lowermost trachea, carina and bilateral primary bronchi causing 60% narrowing of the lower trachea just before carina, more than 90% narrowing of right main bronchus and 50% luminal narrowing of left main bronchus. Carinal resection and reconstruction were successfully performed under general anaesthesia. Patient was managed with conventional orotracheal intubation with Micro laryngeal endotracheal tube and positioned in left principal bronchus railroaded over a paediatric bronchoscope for lung isolation. After thoracotomy, the left main bronchus was intubated directly across the operative field with a sterile flexometallic endotracheal tube. With intermittent ventilation, anastomosis was completed. During anastomosis Micro laryngeal endotracheal tube cuff was damaged twice and we had to reintubate the patient twice in lateral position itself. At the end of anastomoses, flexometallic tube was removed and wound repaired. After confirming no leakage at anastomotic site, Micro laryngeal endotracheal tube was removed and Laryngeal Mask Airway was inserted and bronchial toileting done with adult bronchoscope. Meticulous planning and communication between the anaesthesia and surgical teams are mandatory for the safe and successful anaesthetic management of carinal resection surgeries.
{"title":"Anaesthetic challenges of carinal resection and reconstruction: A case report.","authors":"Ganapathy Arumugam C, Kavitha Sekar, R Sridhar, Ajay Narasimhan, R Narasimhan","doi":"10.4103/lungindia.lungindia_154_24","DOIUrl":"10.4103/lungindia.lungindia_154_24","url":null,"abstract":"<p><strong>Abstract: </strong>Carinal resection of tumour involving trachea and carina remains as a challenge for thoracic surgeons and anaesthesiologists. Resection is technically demanding and can be associated with significant morbidity and mortality. In this case report, we describe the successful management of carinal tumour with carinal resection in a 45-year-old female. The tumour was involving lowermost trachea, carina and bilateral primary bronchi causing 60% narrowing of the lower trachea just before carina, more than 90% narrowing of right main bronchus and 50% luminal narrowing of left main bronchus. Carinal resection and reconstruction were successfully performed under general anaesthesia. Patient was managed with conventional orotracheal intubation with Micro laryngeal endotracheal tube and positioned in left principal bronchus railroaded over a paediatric bronchoscope for lung isolation. After thoracotomy, the left main bronchus was intubated directly across the operative field with a sterile flexometallic endotracheal tube. With intermittent ventilation, anastomosis was completed. During anastomosis Micro laryngeal endotracheal tube cuff was damaged twice and we had to reintubate the patient twice in lateral position itself. At the end of anastomoses, flexometallic tube was removed and wound repaired. After confirming no leakage at anastomotic site, Micro laryngeal endotracheal tube was removed and Laryngeal Mask Airway was inserted and bronchial toileting done with adult bronchoscope. Meticulous planning and communication between the anaesthesia and surgical teams are mandatory for the safe and successful anaesthetic management of carinal resection surgeries.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"371-374"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472991/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-01Epub Date: 2024-08-31DOI: 10.4103/lungindia.lungindia_485_23
Vivekan R Chada, Krishna M Gulla, Rashmi R Das, Ketan Kumar
Objectives: The primary objective was to determine normative values of oxygen saturation (SpO2) by pulse oximetry in apparently healthy children, aged 1 month to 14 years. The secondary objective was to explore any variation in oxygen saturation levels by age and gender.
Materials and methods: It was a cross-sectional study conducted at a tertiary care centre and schools in Bhubaneswar, Odisha, India, from January 2021 to December 2022. Apparently healthy children were enrolled. Using a standardized pulse oximeter and appropriately sized probes, SpO2 was recorded after stabilization of plethysmograph waves. Three consecutive readings were taken, and an average was noted. The 2.5th centile SpO2 value was taken as the lower limit of normal.
Results: The median (IQR) saturation of the sample population was 99.7% (99-100). The 2.5th, 5th, 25th, and 75th percentiles were 97.7%, 98%, 99%, and 100%, respectively. Median SpO2 and its percentiles were estimated for each age group. The 2.5th centile SpO2 for infantile age group was 96.4%. No significant age and gender-wise variations of SpO2 were noted.
Conclusions: The present study established normal reference range oxygen SpO2 levels in apparently healthy children from an eastern India region that is situated at 62 m (204 ft) above the sea level.
{"title":"Normative values of oxygen saturation by pulse oximetry (SpO2) in apparently healthy children from Eastern India - A cross-sectional study.","authors":"Vivekan R Chada, Krishna M Gulla, Rashmi R Das, Ketan Kumar","doi":"10.4103/lungindia.lungindia_485_23","DOIUrl":"10.4103/lungindia.lungindia_485_23","url":null,"abstract":"<p><strong>Objectives: </strong>The primary objective was to determine normative values of oxygen saturation (SpO2) by pulse oximetry in apparently healthy children, aged 1 month to 14 years. The secondary objective was to explore any variation in oxygen saturation levels by age and gender.</p><p><strong>Materials and methods: </strong>It was a cross-sectional study conducted at a tertiary care centre and schools in Bhubaneswar, Odisha, India, from January 2021 to December 2022. Apparently healthy children were enrolled. Using a standardized pulse oximeter and appropriately sized probes, SpO2 was recorded after stabilization of plethysmograph waves. Three consecutive readings were taken, and an average was noted. The 2.5th centile SpO2 value was taken as the lower limit of normal.</p><p><strong>Results: </strong>The median (IQR) saturation of the sample population was 99.7% (99-100). The 2.5th, 5th, 25th, and 75th percentiles were 97.7%, 98%, 99%, and 100%, respectively. Median SpO2 and its percentiles were estimated for each age group. The 2.5th centile SpO2 for infantile age group was 96.4%. No significant age and gender-wise variations of SpO2 were noted.</p><p><strong>Conclusions: </strong>The present study established normal reference range oxygen SpO2 levels in apparently healthy children from an eastern India region that is situated at 62 m (204 ft) above the sea level.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"362-365"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472994/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background and objective: There is a need for simple functional test to assess treatment response in chronic pulmonary aspergillosis (CPA) in resource-constrained settings. The one-minute-sit-to-stand test (1-min-STS) is one such test. However, the minimal important difference (MID) for 1-min-STS in subjects with CPA remains unknown. Herein, we estimate the MID for 1-min-STS for CPA subjects.
Materials and methods: We retrospectively reviewed the clinical details of CPA subjects treated with oral azoles for 6 months. We included only subjects who completed the 1-min-STS test at baseline and 6 months. We used the change in VAS (visual analogue scale, for overall improvement) as an external anchor. We used the anchor and the distribution (standard deviation-based) methods to determine the MID estimates. We used the anchor-based method only if there was correlation of 0.3 with the 1-min-STS test.
Results: One hundred-eight subjects completed the 1-min-STS test at baseline and 6 months. We did not find significant correlation between the change in VAS for overall improvement (r2 = 0.024, P value = 0.809) and the 1-min-STS test. The MID for the 1-min-STS test was 2 repetitions (range, 1.5-2.8 repetitions).
Conclusion: The MID for the 1-min-STS test in subjects with CPA was 2 repetitions. Future studies using a global rating of change scale as an anchor must confirm our findings.
{"title":"The minimal important difference of one-minute-sit-to-stand test in subjects with chronic pulmonary aspergillosis.","authors":"Inderpaul Singh Sehgal, Sahajal Dhooria, Valliappan Muthu, Kuruswamy Thurai Prasad, Kathirvel Soundappan, Ashutosh Nath Aggarwal, Arunaloke Chakrabarti, Shivaprakash Mandya Rudramurthy, Ritesh Agarwal","doi":"10.4103/lungindia.lungindia_168_24","DOIUrl":"10.4103/lungindia.lungindia_168_24","url":null,"abstract":"<p><strong>Background and objective: </strong>There is a need for simple functional test to assess treatment response in chronic pulmonary aspergillosis (CPA) in resource-constrained settings. The one-minute-sit-to-stand test (1-min-STS) is one such test. However, the minimal important difference (MID) for 1-min-STS in subjects with CPA remains unknown. Herein, we estimate the MID for 1-min-STS for CPA subjects.</p><p><strong>Materials and methods: </strong>We retrospectively reviewed the clinical details of CPA subjects treated with oral azoles for 6 months. We included only subjects who completed the 1-min-STS test at baseline and 6 months. We used the change in VAS (visual analogue scale, for overall improvement) as an external anchor. We used the anchor and the distribution (standard deviation-based) methods to determine the MID estimates. We used the anchor-based method only if there was correlation of 0.3 with the 1-min-STS test.</p><p><strong>Results: </strong>One hundred-eight subjects completed the 1-min-STS test at baseline and 6 months. We did not find significant correlation between the change in VAS for overall improvement (r2 = 0.024, P value = 0.809) and the 1-min-STS test. The MID for the 1-min-STS test was 2 repetitions (range, 1.5-2.8 repetitions).</p><p><strong>Conclusion: </strong>The MID for the 1-min-STS test in subjects with CPA was 2 repetitions. Future studies using a global rating of change scale as an anchor must confirm our findings.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"353-356"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472996/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}